New Delhi: There has been a steady decline in Kovid-19 cases in the country for the last few days. Meanwhile, new information has come out on the delta variant in the study of All India Institute of Medical Sciences (AIIMS). Two separate studies conducted at AIIMS in collaboration with the Institute of Genomics and Integrative Biology (IGIB) and the National Center for Disease Control (NCDC) have shown that the delta variant (B.1.617.2) of Kovid-19 is the covidshield or Covaccine can infect people even after taking one or both doses of the vaccine.
The AIIMS study included 63 people who had a breakthrough infection. Of these, 36 were given two doses and 27 had given one dose. In the study of AIIMS-IGIB, no difference was found between the two-dose group and the one-dose group. None of the 63 people died, but in almost all cases there was a high fever for 5-7 days.
The study included 51 men and 22 women
About 60 percent of those taking either Covishield or both doses of Covaccine and 77 percent of those taking a single dose had the delta variant. There were symptoms. Out of 63, 10 were given Covaccine and 53 were given Covishield dose. Of these, 51 were men and 22 were women. In the NCDC study, 27 patients who had the delta variant who were given the Kovidhield vaccine had an infection rate of 70.3 percent.
Both vaccines effective against delta variants
Both studies say that either Covishield or Covaccine are both effective against delta variants but with less effectiveness. It also said that in each case, it has no effect on the outcome of the severity of the infection. It is worth noting that the delta variant is believed to be responsible for the second wave of corona in India.